[LRMR] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -8.34%
YoY- -11.53%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -21,627 -14,654 -12,993 -9,064 -8,366 -6,526 -9,425 74.05%
Tax 0 37 37 -76 -46 -1,111 -1,014 -
NP -21,627 -14,654 -12,993 -9,064 -8,366 -5,415 -8,411 87.79%
Tax Rate - - - - - - - -
Total Cost 21,627 14,654 12,993 9,064 8,366 5,415 8,411 87.79%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.34 -0.27 -0.30 -0.21 -0.19 -0.12 -0.35 -1.91%
EPS Diluted -0.34 -0.27 -0.30 -0.21 -0.19 -0.12 -0.35 -1.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.